Evaluation of Cancer-Based Criteria for Use in Mainstream<i>BRCA1</i>and<i>BRCA2</i>Genetic Testing in Patients With Breast Cancer

Abstract

This study suggests that mainstream testing using simple, cancer-based criteria might be able to efficiently deliver consistent, cost-effective, patient-centered BRCA testing.